SLC14A1 and COVID-19: In addition, we identified features (e.g., SLC14A1, Adipoylcarnitine) for which no direct roles in influencing disease severity have previously been reported: further research may provide important insights into their roles in COVID-19 pathogenesis and whether they might be useful targets for therapeutic intervention.